Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Estratificación de la severidad de la fatiga en el síndrome de COVID persistente: nuevas estrategias terapéuticas

IP: José Alegre Martin
Collaborators: PATRICIA LAUNOIS OBREGÓN, Ramón Sanmartín Sentañes
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 109998
Reference: MUTUA_MADRILEÑA/2022/ALEGRE
Duration: 20/07/2022 - 19/07/2025

Disfunción autonómica y ritmo circadiano en el Síndrome de Fatiga Crónica/Encefalomielitis Miálgica: nuevas herramientas diagnósticas y terapéuticas en la enfermedad

IP: José Alegre Martin
Collaborators: Jesus Castro Marrero, Jesus Castro Marrero
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/00629
Duration: 01/01/2020 - 30/06/2024

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Ana Maria Gonzalez Castro, Elba Exposito Fernandez, Marc Pigrau Pastor, Xavier Serra Ruiz, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota, José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC2019
Duration: 01/01/2020 - 31/12/2024

European Network on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (EUROMENE)

IP: Jesus Castro Marrero
Collaborators: José Alegre Martin
Funding agency: EUROPEAN COMMISSION
Funding: 52000
Reference: EUROMENE_CA15111_COST2015
Duration: 21/04/2016 - 20/04/2020

Related news

The head of the Rheumatology Service at Vall d'Hebron University Hospital and of the Rheumatology research group at VHIR is a highly accomplished rheumatologist with a distinguished career in the field.

It is the first international multi-centre clinical trial to analyse the safety and effect of this treatment for an autoimmune disease.

Els estudis avançaran en els camps de les malalties digestives, el VIH, la fatiga crònica, les patologies cardíaques, l’hepatitis, la diabetis i l’oftalmologia.

Related professionals

Concepció Jacobs Cachá

Concepció Jacobs Cachá

Main researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Sabina Salicrú Riera

Sabina Salicrú Riera

Biomedical Research in Gynaecology
Read more
Ana Torcida Alonso

Ana Torcida Alonso

Research technician
Stroke research
Read more
Victoria Reyes López

Victoria Reyes López

Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.